GRAIL, AstraZeneca partner to develop CDx assays for early-stage cancer
Under the deal, GRAIL's methylation platform will be used to identify patients in the early stages of disease…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Jun 22
Under the deal, GRAIL's methylation platform will be used to identify patients in the early stages of disease…
03 Jun 22
The partnership will enable Accuray to use Limbus' technology to streamline the treatment planning process and improve operational…
03 Jun 22
The partnership will layer Nucleai’s cutting-edge AI spatial models on top of Ultivue’s imaging technology to unlock the…
02 Jun 22
The test is a qualitative next-generation sequencing (NGS)-based in vitro diagnostic technology that uses cfDNA isolated from human…
02 Jun 22
CorDx is transforming the global diagnostics industry with innovative R&D solutions, a vertically integrated supply chain, and manufacturing…
02 Jun 22
Funding will support the commercial launch of Selux’s Next-Generation Phenotyping rapid antimicrobial susceptibility testing platform
31 May 22
The company claims that its new autonomous phlebotomy device will enable almost complete automation of the pre-analytical phase…
31 May 22
The study will recruit 45 patients in a phase 1/2 study to assess the safety and efficacy of…
31 May 22
The platform generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade
31 May 22
DeepVerge is an environmental and life science group that develops and applies AI and IoT technology for the…